Back to Results

Neximmune Inc (NEXI)

NexImmune, Inc. is a clinical-stage biotechnology company focused on developing T cell immunotherapy candidates for cancer and other serious immune-mediated diseases in the United States. The company’s approach is built around its proprietary Artificial Immune Modulation platform, a directly injectable in vivo modality designed to guide immune responses. Its pipeline includes NEXI-001, an allogeneic cell therapy in Phase I/II trials for acute myeloid leukemia; NEXI-002, an autologous cell therapy in Phase I/II trials for relapsed and/or refractory multiple myeloma; and NEXI-003, a Phase I/II candidate directed at HPV-related cancers. NexImmune is also advancing NEXI-004, which remains in preclinical development for EBV-related diseases. Incorporated in 2011, the company is headquartered in Gaithersburg, Maryland.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Market Cap
OTC-NEXI	Not available	Not available	Not available	Weak	0.0%	0.139 K

Smart Snapshot

Stock Overview

A fast read of the company and market metrics currently supported by the latest data.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Quality & Risk

Financial Health

Weak

Valuation • Fair Value

Neximmune Inc (OTC-NEXI) Fair Value by Valuation Model

No usable valuation estimate is currently available for Neximmune Inc (OTC-NEXI); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Neximmune Inc (OTC-NEXI). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Neximmune Inc (OTC-NEXI)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Neximmune Inc (OTC-NEXI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Neximmune Inc (OTC-NEXI)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Neximmune Inc (OTC-NEXI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Neximmune Inc (OTC-NEXI)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Neximmune Inc (OTC-NEXI). No upcoming dividend amount or event date is currently available.

Stock Forecast • Technical Outlook

Neximmune Inc (OTC-NEXI) Stock Forecast & Technical Outlook

Review Neximmune Inc (OTC-NEXI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: daily • daily

Strong Buy

The daily technical read for Neximmune Inc (OTC-NEXI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: weekly • weekly

Strong Buy

The weekly technical read for Neximmune Inc (OTC-NEXI) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy

Time frame: monthly • monthly

Sell

The monthly technical read for Neximmune Inc (OTC-NEXI) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Neximmune Inc (OTC-NEXI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy

Consolidated analyst recommendation mix

Hold

Based on the available recommendation mix, Neximmune Inc (OTC-NEXI) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0

Hold 1

Sell 0

FAQ • Fast Investor Answers

Neximmune Inc (OTC-NEXI) Stock FAQ

Data-supported answers about Neximmune Inc (OTC-NEXI), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value

Not available

No reliable estimate from the currently supported inputs

Financial Health

Weak

Current financial-health read

A reliable fair value estimate is not currently available for Neximmune Inc (OTC-NEXI). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Neximmune Inc (OTC-NEXI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Neximmune Inc (OTC-NEXI).

The current market capitalization listed for Neximmune Inc is 0.139 K.

The ticker symbol for Neximmune Inc is OTC-NEXI, and the stock is listed on OTC Markets.

Neximmune Inc (OTC-NEXI) is listed on OTC Markets.